It has been shown to promote prostate cancer cell proliferation.[52] RECWAS identified 3 novel peaks near PCAT1 that may pinpoint enhancer regions driving its tumorigenesis in prostate cancer. This evidence concerns the gene PCAT1 and prostate cancer.